Establishing a whole blood CD4(+) T cell immunity measurement to predict response to anti-PD-1

BACKGROUND: Biomarkers that can accurately predict the efficacy of immune checkpoint inhibitors (ICIs) against programmed death 1 (PD-1) ligand in cancer immunotherapy are urgently needed. We have previously reported a novel formula that predicts the response to treatment with second-line nivolumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Ou, Atarashi, Kazuyuki, Yoshimura, Kenichi, Shiono, Ayako, Mouri, Atsuhito, Nishihara, Fuyumi, Miura, Yu, Hashimoto, Kosuke, Miyamoto, Yoshiaki, Uga, Hitoshi, Seki, Nobuo, Matsushima, Tomoko, Kikukawa, Norihiro, Kobayashi, Kunihiko, Kaira, Kyoichi, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759885/
https://www.ncbi.nlm.nih.gov/pubmed/36528575
http://dx.doi.org/10.1186/s12885-022-10445-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759885/
https://www.ncbi.nlm.nih.gov/pubmed/36528575
http://dx.doi.org/10.1186/s12885-022-10445-2

Ejemplares similares